Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for Priority Review to be given. Explore more details here.

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

At the halfway point of the high school basketball season, Portland has a firm grip on the CAAC White title. Leading the way ...

Las Vegas officers on patrol with the Metropolitan Police Department will soon be featured on the TV show “On Patrol: Live” ...

The American Association of University Women of Iowa is celebrating the anniversary of a law aimed to fight pay ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we ...

FireAid, featuring Billie Eilish, Lady Gaga, Sting, Red Hot Chili Peppers and others in a fundraiser for Los Angeles-area ...

Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.